We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+44.45%
3 Year Est. Return
+134.49%
5 Year Est. Return
+186.16%
10 Year Est. Return
+747.69%
AUM
$2.06B
AUM Growth
+$100M
Cap. Flow
-$68.5M
Cap. Flow %
-3.33%
Top 10 Hldgs %
18.21%
Holding
130
New
12
Increased
14
Reduced
78
Closed
4

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$17M
2
HHH icon
Howard Hughes
HHH
+$11.4M
3
PHG icon
Philips
PHG
+$9.13M
4
VET icon
Vermilion Energy
VET
+$4.62M
5
LDOS icon
Leidos
LDOS
+$4.45M

Top Sells

Rank Stock Value
1
RYN icon
Rayonier
RYN
+$19.6M
2
UL icon
Unilever
UL
+$7.77M
3
CSCO icon
Cisco
CSCO
+$7.31M
4
GILD icon
Gilead Sciences
GILD
+$6.93M
5
SAIC icon
Saic
SAIC
+$5.37M

Sector Composition

Rank Sector Weight
1 Industrials 25.46%
2 Technology 15.58%
3 Consumer Staples 11.46%
4 Healthcare 10.55%
5 Materials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROK icon
26
Rockwell Automation
ROK
$46.9B
$28.1M 1.37%
238,165
-27,845
-10% -$3.09M
BCR
27
DELISTED
CR Bard Inc.
BCR
$27.6M 1.34%
206,035
-21,440
-9% -$2.83M
DRC
28
DELISTED
DRESSER-RAND GROUP INC
DRC
$27.4M 1.33%
459,155
-6,835
-1% -$405K
FLR icon
29
Fluor
FLR
$7.07B
$26.2M 1.27%
326,360
-30,900
-9% -$2.36M
PG icon
30
Procter & Gamble
PG
$343B
$26M 1.26%
319,489
-19,197
-6% -$1.56M
KMP
31
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$25.6M 1.25%
318,000
-3,900
-1% -$315K
MET icon
32
MetLife
MET
$62B
$25.1M 1.22%
522,560
-6,917
-1% -$310K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$24.9M 1.21%
432,708
-12,817
-3% -$746K
DE icon
34
Deere & Co
DE
$181B
$24.7M 1.2%
270,971
-4,555
-2% -$386K
MKC icon
35
McCormick & Company Non-Voting
MKC
$13.6B
$24.5M 1.19%
712,160
-36,430
-5% -$1.24M
SKM icon
36
SK Telecom
SKM
$13.7B
$24.5M 1.19%
604,011
-27,375
-4% -$1.08M
TNH
37
DELISTED
Terra Nitrogen
TNH
$24.4M 1.19%
172,850
-2,250
-1% -$401K
HON icon
38
Honeywell
HON
$65.7B
$24.3M 1.18%
296,255
-13,646
-4% -$1.07M
XOM icon
39
ExxonMobil
XOM
$678B
$23.8M 1.16%
234,911
+1,290
+0.6% +$119K
KMB icon
40
Kimberly-Clark
KMB
$32.7B
$23.4M 1.14%
233,848
-8,923
-4% -$890K
WBD icon
41
Warner Bros
WBD
$70.3B
$22.6M 1.1%
489,250
TXN icon
42
Texas Instruments
TXN
$242B
$22.6M 1.1%
514,580
+1,000
+0.2% +$41.9K
BDC icon
43
Belden
BDC
$4.48B
$22.5M 1.1%
320,000
-14,000
-4% -$947K
GBX icon
44
The Greenbrier Companies
GBX
$1.34B
$22.3M 1.08%
678,490
-30,535
-4% -$897K
A icon
45
Agilent Technologies
A
$43.3B
$22.2M 1.08%
541,865
+49,573
+10% +$1.88M
DCI icon
46
Donaldson
DCI
$10.1B
$22.1M 1.07%
508,000
BHP icon
47
BHP
BHP
$217B
$22M 1.07%
381,060
-12,146
-3% -$703K
AAPL icon
48
Apple
AAPL
$4.85T
$21.8M 1.06%
1,089,340
+30,380
+3% +$574K
WLY icon
49
John Wiley & Sons Class A
WLY
$2.49B
$21.6M 1.05%
390,600
-2,850
-0.7% -$144K
FCX icon
50
Freeport-McMoran
FCX
$100B
$21M 1.02%
556,610
+13,530
+2% +$480K

Similar funds

Bowen Hanes & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Bowen Hanes & Co held 130 positions worth $2.06B, up 5.1% from $1.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bowen Hanes & Co withdrew a net $68.5M in Q4 2013, closing 4 positions and reducing 78 holdings. Its most notable exit was Rayonier, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Bowen Hanes & Co opened a new position in Visa worth $18.8M.

  • Bowen Hanes & Co's largest Q4 2013 buy was Visa: 337,300 shares worth $18.8M.
  • Bowen Hanes & Co added most to Leidos in Q4 2013, an estimated $4.45M increase.
  • Bowen Hanes & Co's biggest Q4 2013 reduction was Unilever, cutting an estimated $7.77M.
  • Bowen Hanes & Co fully exited Rayonier in Q4 2013, selling an estimated $19.6M.
  • Bowen Hanes & Co's ten largest holdings make up 18% of its $2.06B portfolio in Q4 2013.
  • Bowen Hanes & Co opened 12 new positions and closed 4 in Q4 2013.
  • Bowen Hanes & Co's portfolio value rose 5.1% quarter-over-quarter to $2.06B.

Based on Bowen Hanes & Co's 13F filing for Q4 2013, filed 18 Feb 2014.